HK Stock MarketDetailed Quotes

02170 BASECARE-B

Watchlist
  • 3.060
  • +0.060+2.00%
Market Closed Nov 15 16:08 CST
836.99MMarket Cap-3053P/E (TTM)

About BASECARE-B Company

Beckham's mission Let more families have healthy babies We focus on the application and research of genetic technology in the field of fertility to help patients who are infertile “have children”, so that patients carrying genes of family genetic diseases can “have eugenics” and contribute to the eugenics of the country and nation. Beckon's vision Become the world's leading genetic technology company Providing comprehensive third-generation test tube solutions for clinical institutions As a leading enterprise in the field of reproduction in the NGS segment, Suzhou Beikang Medical Co., Ltd. is committed to the R&D and clinical application of high-throughput sequencing technology in the field of reproductive health. It is a “unicorn” cultivation enterprise in Suzhou. The B3 building has a 1,364-square-meter production center, and the A3 building has a 6271-square-meter research center. Since its establishment, the company has always adhered to the concept of “making compliant products” and has adhered to the path of compliant research and development, registration and certification. In 2015, we reported that the National Standard Management Center defined the PGT-A kit as “three types of medical devices” for supervision; in 2016, the kit successfully obtained the “National Special Approval for Innovative Medical Devices” and entered clinical trials; in 2017, we participated in formulating the PGT-A quality control evaluation guidelines to fill the gaps in China's third-generation IVF quality control technology standards; in the same year, we built a standard clean production workshop that met regulations and GMP requirements and passed the provincial medical inspection laboratory. In 2019, we completed big data verification of the third-generation IVF PGT-A clinical trial; on February 21, 2020, the product was approved for listing by the China Drug Administration, marking the entry of China's third-generation IVF technology into the proven era of medical device supervision, filling a gap in the country. In the future, we will continue to focus on the application and research of genetic technology in the field of fertility to help infertility patients “have children” and allow patients with genes of family genetic diseases to “have eugenics.” We hope that through technological innovation, lives will be changed, more families will be able to give birth to healthy babies, contribute to the eugenics of countries and nations, and continue to advance towards international brands in the field of reproduction. Beckham culture Beckon's values Beckon people adhere to the concept of “strive for every second in everything, Beckham's speed; demand perfection in everything, Beckham standards; do your best in everything, the Beckham spirit” to do everything well. Bay, the base homonym represents the smallest unit of human genetic information; the Kang, Care homonym represents the care and care of human health. Beckon's journey Ten years of thanksgiving, walking through ups and downs Ten years of ups and downs, spring and autumn; ten years of splendor and majesty; thankful for ten years, your peers have you. Looking back on these ten years, I am full of hardships and sweat, and at the same time full of passion and hope. Thank you Beckon people, who carefully polish our products and do a good job of service; being grateful to those who have helped and supported us is your encouragement and keeps us moving forward.

Company Profile

Symbol02170
Company NameBASECARE-B
ISINCNE100004BC1
Listing DateFeb 8, 2021
Issue Price27.36
Shares Offered66.67M share(s)
FoundedDec 14, 2010
Registered AddressChina
Chairmanbo liang
Secretaryminghuiyinlejun zhong
Audit InstitutionKPMG
Company CategoryOther
Registered OfficeRoom 101, Building A3, Bio-Nano Park, No. 218, Xinghu Street, Suzhou Industrial Park, Suzhou, Jiangsu, China
Head Office and Principal Place of Business40th Floor, Dah Sing Finance Centre, 248 Queen's Road East, Wan Chai, Hong Kong
Fiscal Year Ends12-31
Employees528
MarketHong Kong motherboard
Phone(400)1887878
Emailir@basecare.cn
Business Suzhou Beikang Medical Co., Ltd. (former name: Jiangsu Shuangheli Biotechnology Co., Ltd.) is a Chinese investment holding company that mainly provides genetic testing solutions for assisted reproduction. The company provides genetic testing solutions and sells genetic testing equipment and instruments. Genetic testing solutions include the sale of test kits and the provision of testing services. The company's main products include PGT-A kits. The company mainly operates in the domestic market.

Company Executives

  • Name
  • Position
  • Salary
  • bo liang
  • Chairman, Executive Director, General Manager, Chairman of the Nomination Committee, Remuneration Committee Members, Authorized Representative
  • --
  • lingyin kong
  • Executive Director, Technical Director
  • --
  • juanchao jiang
  • Executive Director
  • --
  • wenbo xu
  • Non-executive Directors
  • --
  • ying yang
  • Director of Quality
  • 677.00K
  • weipeng wang
  • Non-executive Directors, Audit Committee Members
  • --
  • yang ling
  • Non-executive Directors
  • --
  • xixiong kang
  • Independent Non-Executive Director, Remuneration Committee Chairman, Nomination Committee Members, Audit Committee Members
  • --
  • zhaorong lin
  • Independent Non-Executive Director, Chairman of the Audit Committee, Member of the Remuneration and Assessment Committee, Nomination Committee Members
  • 84.00K
  • shubiao yang
  • Independent Non-Executive Director
  • 70.00K
  • lijuan shi
  • Employee Supervisors
  • 186.00K
  • yi lin
  • Auditors
  • --
  • qiuping zong
  • Employee Supervisors
  • 189.00K
  • lejun yin
  • Chief Financial Officer, Joint Company Secretary
  • --
  • minghui zhong
  • Joint Company Secretary, Authorized Representative
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data